Cargando…
CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells
Recent advances in genome editing with programmable nucleases have opened up new avenues for multiple applications, from basic research to clinical therapy. The ease of use of the technology—and particularly clustered regularly interspaced short palindromic repeats (CRISPR)—will allow us to improve...
Autores principales: | Kim, Eun Ji, Kang, Ki Ho, Ju, Ji Hyeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214730/ https://www.ncbi.nlm.nih.gov/pubmed/28049282 http://dx.doi.org/10.3904/kjim.2016.198 |
Ejemplares similares
-
The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy
por: Guo, Ning, et al.
Publicado: (2021) -
FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells
por: Caillaud, Amandine, et al.
Publicado: (2022) -
Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells
por: Kondrashov, Alexander, et al.
Publicado: (2018) -
Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery
por: De Masi, Claudia, et al.
Publicado: (2020) -
Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)